Clinical Report: Investigating Stemness and Malignant Progression in Hereditary Colorectal Cancer Associated with Lynch Syndrome Through Single-Cell RNA Sequencing
Overview
This study utilizes single-cell RNA sequencing to explore the molecular changes during malignant progression in Lynch Syndrome (LS) associated colorectal cancer (CRC). Key findings include increased cancer stem cell markers in malignant tissues compared to benign counterparts.
Background
Lynch Syndrome is an autosomal dominant condition linked to mutations in DNA mismatch repair genes, significantly increasing the risk of colorectal cancer. Understanding the transition from benign to malignant states in LS is crucial for early detection and intervention strategies. This study aims to elucidate the cellular and molecular alterations that occur during this transition.
Data Highlights
Marker
Expression Level
CEACAM5
Reportedly increased in LS
BACE2
Upregulated in LS carcinoma
GPRC5A
Upregulated in LS carcinoma
OLFM4
Upregulated in LS carcinoma
Key Findings
Increased primitive cancer stem cells were identified in LS carcinoma tissues.
High expression of CEACAM5, BACE2, GPRC5A, and OLFM4 was observed in LS epithelium.
Enhanced immune cell infiltration and DNA repair activity were noted in LS carcinoma compared to para-carcinoma.
The mutation burden in LS was significantly higher than in healthy controls.
T cell and macrophage-related tumor immunity was mobilized in LS carcinomas.
Clinical Implications
The findings highlight the importance of monitoring cancer stem cell markers and immune responses in LS patients. This information may assist in developing targeted surveillance and therapeutic strategies for early intervention in colorectal cancer.
Conclusion
This study provides insights into the molecular landscape of Lynch Syndrome-associated colorectal cancer, focusing on cancer stem cells and immune dynamics in malignant progression.
